Paper31754328
Current Progress in CAR-T Cell Therapy for Solid Tumors.
Ma S and 7 others. Int J Biol Sci, 2019. Cited by 403 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Current Progress in CAR-T Cell Therapy for Solid Tumors. Papers, record 31754328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31754328
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunotherapy, Adoptive | Major topic |
| Neoplasms | Major topic |
| Cytokine Release Syndrome | |
| Cytokines | |
| Humans | |
| Treatment Outcome | |
| Tumor Microenvironment |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20,981,101 | The patterns and dynamics of genomic instability in metastatic pancreatic cancer. | Nature | 2010 | https://conductscience.org/library/papers/20981101 | PubMed |
| 2 | 12,509,765 | Targeting tumours with genetically enhanced T lymphocytes. | Nat Rev Cancer | 2003 | https://conductscience.org/library/papers/12509765 | PubMed |
| 3 | 12,427,307 | Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2. | Hum Gene Ther | 2002 | https://conductscience.org/library/papers/12427307 | PubMed |
| 4 | 29,880,908 | Driving cars to the clinic for solid tumors. | Gene Ther | 2018 | https://conductscience.org/library/papers/29880908 | PubMed |
| 5 | 24,876,563 | Current concepts in the diagnosis and management of cytokine release syndrome. | Blood | 2014 | https://conductscience.org/library/papers/24876563 | PubMed |
| 6 | 18,559,619 | Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18559619 | PubMed |
| 7 | 28,405,515 | PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28405515 | PubMed |
| 8 | 17,108,138 | CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/17108138 | PubMed |
| 9 | 27,009,301 | Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China. | Sci China Life Sci | 2016 | https://conductscience.org/library/papers/27009301 | PubMed |
| 10 | 28,929,447 | Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells. | Protein Cell | 2017 | https://conductscience.org/library/papers/28929447 | PubMed |
| 11 | 26,110,321 | Seatbelts in CAR therapy: How Safe Are CARS? | Pharmaceuticals (Basel) | 2015 | https://conductscience.org/library/papers/26110321 | PubMed |
| 12 | 23,839,099 | TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. | Mol Ther Nucleic Acids | 2013 | https://conductscience.org/library/papers/23839099 | PubMed |
| 13 | 27,145,284 | Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model. | Oncotarget | 2016 | https://conductscience.org/library/papers/27145284 | PubMed |
| 14 | 23,939,024 | Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. | Mol Ther | 2013 | https://conductscience.org/library/papers/23939024 | PubMed |
| 15 | 18,767,947 | EGF receptor variant III as a target antigen for tumor immunotherapy. | Expert Rev Vaccines | 2008 | https://conductscience.org/library/papers/18767947 | PubMed |
| 16 | 19,384,291 | Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. | Mol Ther | 2009 | https://conductscience.org/library/papers/19384291 | PubMed |
| 17 | 24,409,448 | Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo. | Cancer Immunol Res | 2013 | https://conductscience.org/library/papers/24409448 | PubMed |
| 18 | 29,104,305 | Full-length antibodies versus single-chain antibody fragments for a selective impedimetric lectin-based glycoprofiling of prostate specific antigen. | Electrochim Acta | 2017 | https://conductscience.org/library/papers/29104305 | PubMed |
| 19 | 26,330,164 | Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity. | Cancer Res | 2015 | https://conductscience.org/library/papers/26330164 | PubMed |
| 20 | 24,277,834 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24277834 | PubMed |
Cited by313
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 403 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,856,948 | Adoptive cell therapy in lung cancer: progress, challenges, and prospects. | Chin Med J Pulm Crit Care Med | 2026 | https://conductscience.org/library/papers/42856948 | PubMed |
| 42,819,907 | Adoptive T Cell therapy for cancer and autoimmune disease: current advances, challenges, and future directions. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42819907 | PubMed |
| 42,819,036 | The GPR183-oxysterol axis in cancer: immune trafficking, spatial organization, and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819036 | PubMed |
| 42,780,345 | The mechanism of breast cancer stem cells and tumor microenvironment promoting radioresistance in breast cancer and its intervention strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42780345 | PubMed |
| 42,754,891 | Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42754891 | PubMed |
| 42,741,434 | Novel cryopreservation medium for enhanced stability of T cells at -80°C. | Front Hematol | 2024 | https://conductscience.org/library/papers/42741434 | PubMed |
| 42,729,542 | The dual roles of Prevotella in gastrointestinal tumorigenesis: from molecular mechanisms to therapeutic prospects. | Front Oncol | 2026 | https://conductscience.org/library/papers/42729542 | PubMed |
| 42,630,534 | Clinical significance of SNRPD1 expression in predicting post-transplant recurrence of hepatocellular carcinoma. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42630534 | PubMed |
| 42,558,624 | Targeting NOP14 remodels the tumor immune microenvironment and enhances the antitumor efficacy of PD-1 blockade in DLBCL. | Front Immunol | 2026 | https://conductscience.org/library/papers/42558624 | PubMed |
| 42,482,408 | Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions. | Cancer | 2026 | https://conductscience.org/library/papers/42482408 | PubMed |
| 42,441,043 | A narrative review of new strategies for immunotherapy combination treatment in platinum-resistant ovarian cancer: mechanisms, clinical evidence, and future directions. | Front Oncol | 2026 | https://conductscience.org/library/papers/42441043 | PubMed |
| 42,353,619 | Advancements in Immune Checkpoint-Based Immunotherapy for Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42353619 | PubMed |
| 42,332,855 | A Review of Recent Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hepatocellular Carcinoma. | Med Sci Monit | 2026 | https://conductscience.org/library/papers/42332855 | PubMed |
| 42,329,489 | Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review. | Curr Treat Options Oncol | 2026 | https://conductscience.org/library/papers/42329489 | PubMed |
| 42,311,657 | The cGAS-STING pathway in cancer immunotherapy: prognostic value and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42311657 | PubMed |
| 42,163,764 | Advances in Biomarkers for CAR-T Treatment Resistance in Diffuse Large B-Cell Lymphoma. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/42163764 | PubMed |
| 42,116,871 | Customized Marketing Strategies for Cancer Immunocyte Therapy Based on its Distinctive Attributes. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42116871 | PubMed |
| 42,113,250 | Mechanical preconditioning by shear stress enhances memory formation and anti-tumor function of CAR-T cells. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42113250 | PubMed |
| 42,099,215 | Tecartus Real-World Adverse Event Reporting System in a Middle-Aged and Elderly Population: A FAERS-Based Pharmacovigilance Study. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42099215 | PubMed |
| 42,088,834 | Remodeling memory T cells with chemotherapy and immune checkpoint inhibitors as host pre-conditioning to empower in vivo CAR-T therapy. | Synth Syst Biotechnol | 2026 | https://conductscience.org/library/papers/42088834 | PubMed |
Genes58
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31754328
GET https://conductscience.org/api/papers/v1/31754328/references?page=2